SuperworthIntelligent Bio Solutions EPS INBS
Diluted earnings per share by quarter and over the last twelve months, from 2019.
- Last 12 months, to Jun 30, 2026
- −$9.68
- Latest quarter, Q4 FY26
- −$1.56
- Fiscal year 2026
- −$9.68
Intelligent Bio Solutions' earnings per share was −$9.68 over the twelve months to Jun 30, 2026.
In its latest quarter, Q4 FY26, it was −$1.56.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | −$9.68 | n/a |
| FY2025 | −$20.78 | n/a |
| FY2024 | −$168.90 | n/a |
| FY2023 | −$1189.80 | n/a |
| FY2021 | −$1656.00 | n/a |
| FY2020 | −$888.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY26 | −$1.56 | n/a | −$9.68 | |
| Q3 FY26 | −$1.80 | n/a | −$12.53 | |
| Q2 FY26 | −$2.82 | n/a | −$15.14 | |
| Q1 FY26 | −$3.50 | n/a | −$17.28 | |
| Q4 FY25 | −$4.41 | n/a | −$20.78 | |
| Q3 FY25 | −$4.41 | n/a | −$25.47 | |
| Q2 FY25 | −$4.96 | n/a | −$35.36 | |
| Q1 FY25 | −$7.00 | n/a | −$51.10 | |
| Q4 FY24 | −$9.10 | n/a | −$168.90 | |
| Q3 FY24 | −$14.30 | n/a | −$412.90 | |
| Q2 FY24 | −$20.70 | n/a | −$1085.30 | |
| Q1 FY24 | −$124.80 | n/a | −$1120.20 |
Against its peers
Companies in Healthcare nearest Intelligent Bio Solutions' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| INBSIntelligent Bio Solutions | −$9.68 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| CKXCKX Lands | $1.42 | +647% a year |
| MSGMMotorsport Games | $0.43 | +187% a year |
| ATCHAtlasClear | $0.01 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Intelligent Bio Solutions
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.